Analysis – Goldea Capital

The continuing business generated revenue of DKK 396.3 million, compared with DKK 390.1 million in the same period last year. Operating profit (EBIT) was DKK 34.6 million, compared with DKK 31.7 million in the same period last year.

Written by Customer Service on August 26, 2026. Posted in Earnings Releases And Operating Results.

Summary (comparative figures in parentheses): Gabriel Holding A/S’ continuing operations achieved a growth of DKK 6 million, corresponding to 2%. Growth was achieved in both Europe and North America, while in Asia revenue was in line with the same period last year. In the third quarter, continuing operations generated revenue of DKK 133.0 million (DKK 128.6 million), corresponding to a growth of 3%.Operating profit (EBIT) for the continuing business increased by DKK 2.9 million to DKK 34.6 million. (DKK 31.7 million).The Group’s furniture manufacturing activities, FurnMaster, remained held for sale at the end of the third quarter and are reported as discontinued operations. Profit after tax from this amounted to DKK -39.6 million, compared to DKK -6.2 million in the same period last year. Cash flows from operating...

Sportradar Scores with Euroleague Basketball Official Data and AV Betting Rights Deal

Written by Customer Service on August 26, 2026. Posted in Mergers And Acquisitions.

ST. GALLEN, Switzerland and BARCELONA, Spain, Aug. 26, 2026 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ: SRAD), a leading global sports technology company creating immersive experiences for sports fans and bettors, and Euroleague Basketball today announced a multi-year extension of their data and audiovisual (AV) betting rights agreement. The rights were originally secured as part of Sportradar’s acquisition of IMG ARENA in 2025. The agreement renewal begins with the upcoming 2026-27 season and extends Sportradar’s exclusive global distribution of Euroleague Basketball official data and AV betting rights through 2031. The deal covers more than 650 games annually across EuroLeague and BKT EuroCup competitions. The extension of the Euroleague Basketball partnership further enhances Sportradar’s premier global basketball portfolio...

UP Fintech Holding Limited Reports Unaudited Second Quarter 2026 Financial Results

Written by Customer Service on August 26, 2026. Posted in Earnings Releases And Operating Results.

SINGAPORE, Aug. 26, 2026 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (NASDAQ: TIGR) (“UP Fintech” or the “Company”), a leading online brokerage firm focusing on global investors, today announced its unaudited financial results for the second quarter ended June 30, 2026. Mr. Wu Tianhua, Chairman and CEO of UP Fintech stated: “In the second quarter, we saw substantial improvement in both commission income and interest related income compared with both the prior quarter and the same quarter of last year. Our total revenue for the second quarter reached US$182.3 million, hitting an all-time high and representing a sequential increase of 17.7% and a year-over-year growth of 31.4%. Income from operations for the second quarter reached US$56.8 million, representing a quarter-over-quarter increase of 19.5% and year-over-year growth of...

No. 10/2026 – INTERIM REPORT, H1 2026

Written by Customer Service on August 26, 2026. Posted in Earnings Releases And Operating Results.

Nasdaq Copenhagen Nikolaj Plads 6DK-1067 Copenhagen K Copenhagen, 26 August 2026ANNOUNCEMENT no. 10/2026 INTERIM REPORT, H1 2026 The company has today published the Interim Report for H1 2026 (covering the period from 1 January 2026 to 30 June 2026). The Interim Report is attached to this company announcement and can be downloaded from the company’s website www.cemat.dk.Cemat A/S Jaroslaw LipinskiCEOThis announcement has been prepared in a Danish-language and an English-language version. In case of doubt, the Danish version prevails.AttachmentsAnnouncement no. 10 – Interim report H1 2026Cemat – Interim report H1 2026

Nxera Pharma’s Partner Neurocrine Biosciences Receives IND Acceptance from the FDA for Phase 2 Study of NBI-1117567 for Alzheimer’s Cognition

Written by Customer Service on August 26, 2026. Posted in Public Companies.

NBI-1117567 is an investigational oral, muscarinic M1 preferring (M1/M4) selective agonist discovered by Nxera and advancing through clinical development under a multi-program collaboration with Neurocrine Nxera to receive a US$10 million milestone payment upon IND Acceptance, as part of the overall milestone package Nxera retains development and commercialization rights to the M1 receptor agonist for all indications in JapanTokyo, Japan and Cambridge, UK, 26 August 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that its partner Neurocrine Biosciences Inc. (“Neurocrine”) has received IND Acceptance from the U.S. Food and Drug Administration (FDA) for a Phase 2 study of NBI-1117567 (“NBI-’567”) for Alzheimer’s cognition. Nxera will receive an IND Acceptance milestone payment of US$10 million from Neurocrine...

DSC Reports Second Quarter 2026 Unaudited Financial Results

Written by Customer Service on August 26, 2026. Posted in Earnings Releases And Operating Results.

HANGZHOU, China, Aug. 26, 2026 (GLOBE NEWSWIRE) — DSC Holdings Ltd. (“DSC” or the “Company”) (Nasdaq: DSC), the AI application infrastructure for China’s used car industry, today announced its unaudited financial results for the second quarter ended June 30, 2026.FINANCIAL HIGHLIGHTS(Amounts in millions, except per ADS) Q2 2026 Q2 2025 Q2 2026 RMB RMB US$Revenue 167.0 161.1 24.6Net loss (240.5) (25.0) (35.4)Adjusted net loss (non-GAAP) (7.4) (19.2) (1.1)Adjusted basic and diluted net loss per ADS (0.15) (2.82) (0.02) Second quarter revenue increased 3.7% year over year, while adjusted net loss (non-GAAP) narrowed by 61.5%, reflecting continued significant improvement in operating efficiency. GAAP net loss was RMB240.5 million (US$35.4 million), primarily reflecting the recognition of RMB227.8...

FirstFarms A/S’ interim financial report 1 January – 30 June 2026

Written by Customer Service on August 26, 2026. Posted in Earnings Releases And Operating Results.

Half year result impacted by drought in Slovakia and low pig and milk prices FirstFarms A/S reported a pre-tax result of minus 50 mDKK in the first half year of 2026, which is not satisfactory. The first half of the year has been significantly impacted by very low pig and milk prices during the period. In addition, Europe has been affected by drought. As a result, yields in Slovakia are expected to be 35% below the budgeted. In Romania, on the other hand, growing conditions have been particularly favourable, and here we expect yields both on non-irrigated areas and on areas that can be irrigated. FirstFarms has in the accounting period realised:· A turnover of 200 mDKK (2025: 192 mDKK) · An EBITDA of 3 mDKK (2025: 54 mDKK) · An EBIT of -33 mDKK (2025: 22 mDKK) · A pre-tax result of -50 mDKK (2025: 7 mDKK) The turnover is 7 mDKK higher...

4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing

Written by Customer Service on August 26, 2026. Posted in Public Companies.

Commercial collaboration combines 4basebio’s synthetic DNA technology with Genezen’s viral vector development and manufacturing expertise to support gene therapy programs from early development through clinical and commercial manufacturing. CAMBRIDGE, UK and INDIANAPOLIS, IN – 26 August 2026 – 4basebio PLC (AIM: 4BB), a specialist in enzymatically-produced, cell-free DNA for new genetic medicines, and Genezen, a best-in-class viral vector contract development and manufacturing organization (CDMO), today announced an expanded, non-exclusive collaboration providing drug developers access to 4basebio’s Research Use Only, High-Quality, and GMP-grade hpDNA® development and clinical programs. Through the collaboration, Genezen will offer access to 4basebio’s synthetic DNA developed specifically for viral vector applications, creating a more...

FirstFarms adjusts downwards the expectations for the year based on drought in Slovakia and decrease in pig prices

Written by Customer Service on August 26, 2026. Posted in Public Companies.

As a consequence of drought in large parts of Europe, and especially in Slovakia, crop yields in Slovakia are expected to be 35% lower than expected. At the same time, pig prices have decreased over the summer. As a result, FirstFarms adjusts downwards the previous announced expectations for 2026 by 20 mDKK to an EBITDA in the level of minus 5 – 45 mDKK and an EBIT of minus 75 – minus 25 mDKK.Announced expectations 2026 EBITDA EBIT 26 August 2026 minus 5 – 45 mDKK minus 75 – minus 25 mDKK8 July 2026 15 – 65 mDKK minus 55 – minus 5 mDKK25 March 2026 60 – 110 mDKK -10 – +40 mDKKThe crops in Romania are in general good condition, where FirstFarms has more than...

AL Sydbank maintains momentum in Q2

Written by Customer Service on August 26, 2026. Posted in Earnings Releases And Operating Results.

Company Announcement No 47/2026Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37 AL Sydbank A/SCVR No DK 12626509, Aabenraaal-sydbank.com26 August 2026 Dear Sirs AL Sydbank maintains momentum in Q2 AL Sydbank’s half-year report shows that the positive trend from Q1 has been sustained and strengthened in several areas. Profit has improved, lending has increased and the amalgamation of the organisation is proceeding as planned. At the same time, the Bank has delivered a higher return on equity. AL Sydbank continues to build on the momentum established in Q1. Profit for the half-year after tax represented DKK 1.8bn, equalling a return on tangible equity of 13.3% after tax. Bank loans and advances increased by DKK 3.4bn – equivalent to 2.4% – in H1 2026 and constituted DKK 143.7bn at the end of the period. Deposits...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals